Diamedica Therapeutics Inc DMAC

$8.23 -0.12 (-1.44%)

Valuation

Market cap
450,282,000
Revenue TTM
$0
Net income TTM
$-32,770,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
335,600
Avg volume
172,294
Day's range
$8.02 – $8.61
Shares out
53,926,000
Stochastic %K
71%
Beta
0.92
Analysts
Strong Sell
Price target
$15.50

Price

Company profile

DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases. Its lead candidate is DM199, a pharmaceutically active recombinant form of the human tissue kallikrein-1 protein, which is in Phase 2/3 trials for the treatment of acute ischemic stroke, as well as in Phase 2 to treat preeclampsia, cardio renal disease, and fetal g...

Show more

DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases. Its lead candidate is DM199, a pharmaceutically active recombinant form of the human tissue kallikrein-1 protein, which is in Phase 2/3 trials for the treatment of acute ischemic stroke, as well as in Phase 2 to treat preeclampsia, cardio renal disease, and fetal growth restriction. The company develops DM300, which is a recombinant human ulinastatin in the preclinical stage for the treatment of inflammatory diseases, such as acute pancreatitis. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Industry
Biotechnology
Sector
Healthcare
Phone
763 496 5454
Website
https://www.diamedica.com
Address
301 Carlson Parkway, Suite 210, Minneapolis, United States

Latest news

Stocktwits

PumpnRun Oct 1, 6:10 PM
$DMAC Awfully quiet around here and stock keeps going up. Never fails, when I sell they keep going up.
1 replies
PumpnRun Sep 30, 4:35 PM
$DMAC Buy on rumor, sell on news? Back below $7.00 we go.
0 replies
JMforProfits Sep 30, 1:41 PM
$DMAC DiaMedica will hold a key opinion leader (KOL) webinar on October 23 at 8:00 AM ET. The company will present preliminary interim results from the first six patients in its Phase 2 early-onset FGR trial.
1 replies
Stock_picker_trader Sep 30, 1:17 PM
$DMAC https://d1io3yog0oux5.cloudfront.net/_2b16e7e8bf75bfa29153e205613bf05b/diamedica/news/2026-09-30_DiaMedica_Therapeutics_Announces_Key_Opinion_1735.pdf
0 replies
Pegger Sep 28, 2:33 PM
$DMAC moving up steadily with important updates on the horizon and not a peep of news being leaked out. Maybe just maybe 🤔
2 replies
Sukitt Sep 25, 5:25 PM
$DMAC Looks like it's holding in the 7s.
0 replies
JMforProfits Sep 23, 12:02 PM
$DMAC Getting close….. Last week of September for some news….
2 replies
Danger_Will_Robinson Sep 21, 3:55 PM
$DMAC why the share price increase today …. Is this just another head fake … when is readout
1 replies